Co-Authors
This is a "connection" page, showing publications co-authored by Zheng-Li Shi and Mei-Qin Liu.
Connection Strength
1.297
-
Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates. Virol Sin. 2021 Oct; 36(5):879-889.
Score: 0.235
-
Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 12; 588(7836):E6.
Score: 0.229
-
Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2. Cell. 2020 07 09; 182(1):50-58.e8.
Score: 0.221
-
A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 03; 579(7798):270-273.
Score: 0.216
-
Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics. Nat Commun. 2021 08 09; 12(1):4887.
Score: 0.060
-
Genetic Mutation of SARS-CoV-2 during Consecutive Passages in Permissive Cells. Virol Sin. 2021 10; 36(5):1073-1076.
Score: 0.059
-
Stability of SARS-CoV-2 on the Surfaces of Three Meats in the Setting That Simulates the Cold Chain Transportation. Virol Sin. 2021 10; 36(5):1069-1072.
Score: 0.059
-
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol. 2020 06; 17(6):621-630.
Score: 0.055
-
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020 06; 582(7811):289-293.
Score: 0.055
-
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020 Apr; 30(4):343-355.
Score: 0.055
-
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol. 2020 07; 17(7):765-767.
Score: 0.054